Company Profile

DNAmicroarray Inc (AKA: Bioarray Technologies Inc)
Profile last edited on: 1/3/2018      CAGE: 46U93      UEI:

Business Identifier: DNA microarray synthesis and analysis services
Year Founded
1997
First Award
1999
Latest Award
2011
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

9943 Falcon Bluff Street
San Diego, CA 92127
   (858) 866-3437
   info@dnamicroarray.com
   www.dnamicroarray.com
Location: Single
Congr. District: 52
County: San Diego

Public Profile

DNAmicroarray, Inc. - previously doing business as Bioarray Technology Inc. - is organzied around development and commercialization of enabling innovative technologies for diagnostics and therapeutics. The company's broad spectrum of products, services, and R&D is focused on commercially significant areas such as drug discovery, stem cell therapeutics, clinical trials, and agricultural diagnostics. The firm's mission has always been to make affordable and licensed products, services, and technologies available to pharmaceutical, biotechnology, academic, and government researchers. DNAmicroarray, Inc. combines commercially available technologies with in-house developed and proprietary methodologies and a plurality of innovative nanotechnology, microfluidics, MEMS, chemistry, molecular biology, cell biology based advances into enabling low cost products and services.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2011 1 NIH $252,503
Project Title: Human Chemically Induced Pluripotent Stem Cells (Cipsc) Generated Cardiomyocytes
2010 1 NIH $247,244
Project Title: Chemically Induced Pluripotent Stem (Cips) Cells Alzheimer's Patient Specific Cel
2009 1 NIH $240,265
Project Title: Clinically Relevant Cips Cell Lines
2002 2 NIH $1,122,332
Project Title: Online 2D Functional Proteomics
2001 1 NIH $143,121
Project Title: Human protein differential display assay icat-ulc-ms/ms

Key People / Management

Company News

There are no news available.